Whole-blood transfusion has recently gained favor in the management of severe hemorrhage; however, data from large clinical trials evaluating its clinical effectiveness and safety are lacking. We ...

New human research reveals how gut bacteria and creatine may restore brain energy and improve depression. If you have or know ...

The programme enrolled 196 children, adolescents, and adults with either paediatric-onset or adult-onset HPP.

Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...

In an effort to increase access to evidence-based interventions to help manage anxiety and depression, Mass General Brigham ...

Actinogen anticipates final topline efficacy and safety results for the full 36-week treatment period in November 2026.

Oxaliplatin-Based Versus Alkylating Agent in Neuroendocrine Tumors According to the O6-Methylguanine-DNA Methyltransferase Status: A Randomized Phase II Study (MGMT-NET) The median time post-HCT was ...

Patritumab deruxtecan (HER3-DXd) in active brain metastases from metastatic breast and non-small cell lung cancers, and leptomeningeal disease from advanced solid tumors: The TUXEDO-3 phase II trial.

LifeNet Health, a global leader in regenerative medicine, has received the Best Randomized Controlled Trial Award at the 2026 CAMPs Awards for its Matrion® diabetic foot ulcer study. In this ...

Aroa Biosurgery Limited today announced completion of its randomised controlled trial (RCT) evaluating Symphony, with a preliminary study read-out indicating the trial achieved its primary endpoint.